Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tardive dyskinesia.

D E Casey1

  • 1Psychiatry Service, Veterans Administration Medical Center, Portland, OR 97207.

The Western Journal of Medicine
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Tardive dyskinesia, a movement disorder from antipsychotic drugs, affects 20% of patients. Early detection and reduced drug exposure improve outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy.

International journal of clinical practice·2014
Same author

Antipsychotic drugs dose-dependently suppress the spontaneous hyperactivity of the chakragati mouse.

Neuroscience·2010
Same author

Antipsychotic drug-induced weight gain: development of an animal model.

International journal of obesity (2005)·2005
Same author

The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates.

Psychopharmacology·2001
Same author

Effects of benztropine on ketamine-induced behaviors in Cebus monkeys.

Behavioural pharmacology·2001
Same author

Clinical trial design issues in schizophrenic research.

The Journal of clinical psychiatry·2001
Same journal

Does daily use of sunscreen or beta-carotene supplements prevent skin cancer in healthy adults?

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
See all related articles

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Tardive dyskinesia is a serious side effect of long-term neuroleptic treatment.
  • Characterized by involuntary movements, it can include subtypes like tardive dystonia and akathisia.
  • Altered dopaminergic pathways are suspected contributors to its pathophysiology.

Purpose of the Study:

  • To summarize the characteristics, risk factors, and management of tardive dyskinesia.
  • To highlight the correlation between drug exposure and the risk of developing this syndrome.
  • To identify factors associated with favorable long-term outcomes.

Main Methods:

  • Review of existing literature on tardive dyskinesia.
  • Analysis of risk factors including age, sex, and psychiatric diagnoses.
  • Evaluation of management strategies and prognostic indicators.

Related Experiment Videos

Main Results:

  • Tardive dyskinesia affects approximately 20% of patients on neuroleptics, with higher rates in the elderly.
  • Risk factors include advanced age, female sex, affective disorders, and prolonged use of antidopaminergic drugs.
  • Total drug exposure duration is positively correlated with increased risk.

Conclusions:

  • Management involves careful patient evaluation, differential diagnosis, and dose adjustment of neuroleptics.
  • No single treatment is universally effective; minimizing motor side effects is key.
  • Younger age, early detection, reduced drug exposure, and longer follow-up are linked to better outcomes.